A Phase 1 First-in-Human Monotherapy Study of F182112, a B-Cell Maturation Antigen (BCMA)-CD3 Bispecific Antibody, in Patients with Relapsed or Refractory Multiple MyelomaMingyuan Sun,Junyuan Qi,Lugui Qiu,Jie Jin,Xin Li,Yongqiang Wei,Guimin Zhang, Xue Liu, Shaohong YinBlood（2023）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
